April 3, 2019Clinical Pharmacology & Therapeutics40 citations
View Full PaperReal‐World Evidence of Treatment Effects: The Useful and the Misleading
Key Points
Key points are not available for this paper at this time.
Abstract
S.S. is a consultant to WHISCON, LLC, and to Aetion, Inc., of which he also owns equity. He is the principal investigator of grants to the Brigham and Women's Hospital from Bayer, Vertex, and Boehringer Ingelheim unrelated to the topic of this paper.